AbbVie Rallies Alongside Q4 Beats
Roper Technologies delivered strong fourth-quarter results exceeding market expectations, yet concerns linger about long-term ...
Exxon Mobil reported Q4 results with revenues of $83.4B, missing expectations. Adjusted EPS beat at $1.67 & company plans to ...
Reports Q4 revenue $13.2B vs. $11.4B last year. Vas Narasimhan, CEO of Novartis (NVS), said: “In our first full year as a pure-play innovative ...
Nokia's earnings exceeded expectations despite a slight revenue miss.
AbbVie Q4 earnings beat estimates, driven by strong sales of Skyrizi and Rinvoq, with an updated 2027 combined revenue ...
Reports Q4 revenue $3.7B, consensus $3.97B. Tim Knavish, PPG (PPG) chairman and chief executive officer, commented on the year and quarter: ...
AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.
As one of the foremost electric vehicle companies in the world, Tesla continues to be an important company to watch in tech, ...
Northrop Grumman Corp (NYSE:NOC) reported fourth-quarter sales that were flat year over year at $10.686 billion, missing the ...
AbbVie reported strong Q4 results, driven by Skyrizi, Rinvoq, neuroscience products, and eye care. Click here to find out why ...
Swiss drug-major Novartis AG reported Friday weak net earnings in its fourth quarter on the absence of prior year's significant gain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback